Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Baylor Genetics United States | 1 | 142 |
|
Neuromuscular diseases panel_v.2.0 CGC Genetics Unilabs Portugal | 17 | 248 |
|
CGC Genetics Unilabs Portugal | 1 | 181 |
|
Neuromuscular Diseases Panel (Expanded) Mendelics Brazil | 1 | 288 |
|
OnkoSight Advanced Comprehensive Solid Tumor Panel (DNA/RNA) BioReference Health United States | 1 | 523 |
|
OnkoSight Advanced 523 Gene NGS Panel BioReference Health United States | 1 | 523 |
|
MUSCULAR DISORDERS- EMCG GLOBAL EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 416 |
|
Caris Life Sciences United States | 1 | 591 |
|
OncoAlly™ Solid Tumor Analysis Variantyx, Inc. United States | 1 | 433 |
|
Quest Diagnostics Nichols Institute San Juan Capistrano United States | 1 | 523 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Sarcoma Comprehensive NGS Fusion Panel NeoGenomics Laboratories NeoGenomics Laboratories, Inc. United States | 1 | 97 |
|
Caris MI TumorSeek Comprehensive Genomic Profile Caris Life Sciences United States | 1 | 591 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 135 | 136 |
|
Hemato-oncology chromosomal microarray Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 23 | 93 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.